Runaway Biology: A Call for Conscientious Genome Editing with CRISPR
By Søren Hough,
SFTP
| 01. 28. 2021
By 2018, it was clear that CRISPR had spun out of control. In the United States, one biotech company managed to bypass the Food and Drug Administration to get CRISPR-modified food onto people’s dinner plates. Not long after, a world-shaking report revealed that CRISPR had also been used without formal approval in China to edit the DNA of two baby girls, Lulu and Nana. As scientists and governments methodically deliberate on the best way to regulate CRISPR’s use in society, those seeking fame and fortune plow ahead heedless of the consequences. CRISPR, now a Nobel Prize-winning technology, is a permanent fixture in biological research and clinical medicine. We must take its dire ethical implications, from changing the food we eat to altering human evolution, more seriously.
Genetic Reductionism and CRISPR: Dire Bedfellows
When Drs. Jennifer Doudna and Emanuelle Charpentier were awarded the Nobel Prize in Chemistry for their work on CRISPR, the Nobel committee framed their discovery as a tool for rewriting the “code of life” DNA.https://www.nobelprize.org/prizes/chemistry/2020/press-release/." title>1 Describing DNA as the “code of life” is a common trope, and...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...